View Post

New Clinical Trial for Triple-Negative Breast Cancer at Sylvester Comprehensive Cancer Center

In Clinical Trials by Barbara Jacoby

Vaccine Designed to Prevent Recurrence Panic washed over Jackie Barrett when she first received her breast cancer diagnosis. “My eyes went dark. I couldn’t hear anything. It was like a train was coming at me,” she says. Jackie’s oncologist explained that her type of breast cancer is called triple-negative because it does not have receptors for estrogen, progesterone or the …

View Post

UCSF-led clinical trial model may present a better way to test new breast cancer drugs

In In The News by Barbara Jacoby

By Josh Baxt From: medcitynews.com Clinical trials have a long rap sheet: expensive, slow, inaccurate, prone to failure. Patients, researchers, and investors wait impatiently for that elusive signal to show up – often in vain. But now, a UC San Francisco-led group may be developing a better way. Their solution is a platform trial called I-SPY – which stands for Investigating …

View Post

FDA Approves Pembrolizumab for Pancreatic Cancers with Mismatch Repair Deficiency

In In The News by Barbara Jacoby

Source: The Lustgarten Foundation for Pancreatic Cancer Research From: PR Newswire In an unprecedented, fast-tracked review, the Food and Drug Administration (FDA) approved the use of pembrolizumab (anti-PDI) immunotherapy for patients with advanced pancreatic cancers who have a defect in their capacity to repair DNA.  Support from the Lustgarten Foundation was critical to the success of the clinical trial that …

View Post

Stage four cancer now undetectable in man after trial treatment

In In The News by Barbara Jacoby

by CNN Wire From: myfox8.com A Phoenix man with pancreatic cancer, who was told he only had months to live, says he has been given a second chance at life. Phil Zeblisky, a 57-year-old, says doctors at two cancer centers considered his stage four pancreatic cancer a death sentence. “When you’re given that kind of diagnosis, you need to put …